Committee for Medicinal Products for Human Use (CHMP) Biologics Working Party (BWP) stakeholders' meeting on the Guideline on the requirements for quality documentation concerning biological investigational medicinal products (IMP) in clinical trials

Date

Thursday, 16 June 2011, All day

Location

European Medicines Agency, Amsterdam, the Netherlands

The BWP is holding a stakeholder meeting, following the public consultation on the Guideline on the requirements for quality documentation concerning biological investigational medicinal products (IMP) in clinical trials.

Share this page